|
Toll Free: (877) 796-6397 -- USA and Canada only -- |
Fax: +1-832-582-8590 Orders: +1-832-582-8158 |
Tech Support: +1-832-582-8158 Ext:3 Please provide your Order Number in the email. |
Technical Data
| Formula | C24H27Cl3FN5O3 |
|||
| Molecular Weight | 558.86 | CAS No. | 289499-45-2 | |
| Solubility (25°C)* | In vitro | DMSO | 100 mg/mL (178.93 mM) | |
| Water | 20 mg/mL (35.78 mM) | |||
| Ethanol | Insoluble | |||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. * Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.) |
||||
Preparing Stock Solutions
Biological Activity
| Description | Canertinib (CI-1033, PD-183805, compound 18) dihydrochloride is a potent and irreversible inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase. Canertinib dihydrochloride inhibits cellular EGFR and ErbB2 autophosphorylation with IC50 of 7.4 nM and 9 nM, respectively. | ||||
|---|---|---|---|---|---|
| Targets |
|
Protocol (from reference)
Selleck's Canertinib dihydrochloride has been cited by 8 publications
| EmCyclinD-EmCDK4/6 complex is involved in the host EGF-mediated proliferation of Echinococcus multilocularis germinative cells via the EGFR-ERK pathway [ Front Microbiol, 2022, 13:968872] | PubMed: 36033888 |
| Acidosis-induced activation of distal nephron principal cells triggers Gdf15 secretion and adaptive proliferation of intercalated cells [ Acta Physiol (Oxf), 2021, 10.1111/apha.13661] | PubMed: 33840159 |
| [ Sci Rep, 2017, ] | PubMed: 28638122 |
| [ BMC Cancer, 2017, ] | PubMed: 28806950 |
| MDM2 facilitates adipocyte differentiation through CRTC-mediated activation of STAT3 [ Cell Death Dis, 2016, 7(6):e2289] | PubMed: 27362806 |
| [ Oncotarget, 2015, ] | PubMed: 25686822 |
| [ Oncotarget, 2015, ] | PubMed: 25965827 |
| Angiogenesis and its therapeutic opportunities [ Mediators Inflamm, 2013, 2013:127170] | PubMed: 23983401 |
RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.
NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.